CVS Health Corp (CVS) : Exchange Capital Management reduced its stake in CVS Health Corp by 2.05% during the most recent quarter end. The investment management company now holds a total of 57,224 shares of CVS Health Corp which is valued at $5,850,582 after selling 1,200 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Apr 12, 2016.CVS Health Corp makes up approximately 2.49% of Exchange Capital Management’s portfolio.
CVS Health Corp opened for trading at $100.95 and hit $102.38 on the upside on Friday, eventually ending the session at $102.24, with a gain of 1.12% or 1.13 points. The heightened volatility saw the trading volume jump to 32,73,923 shares. Company has a market cap of $112,310 M.
Other Hedge Funds, Including , Prospera Financial Services Inc reduced its stake in CVS by selling 1,406 shares or 28.48% in the most recent quarter. The Hedge Fund company now holds 3,530 shares of CVS which is valued at $360,907. CVS Health Corp makes up approx 0.08% of Prospera Financial Services Inc’s portfolio.Peachtree Investment Advisors boosted its stake in CVS in the latest quarter, The investment management firm added 200 additional shares and now holds a total of 3,500 shares of CVS Health Corp which is valued at $357,840. CVS Health Corp makes up approx 0.35% of Peachtree Investment Advisors’s portfolio.Waverton Investment Management Ltd reduced its stake in CVS by selling 8,867 shares or 14.13% in the most recent quarter. The Hedge Fund company now holds 53,903 shares of CVS which is valued at $5,431,805. CVS Health Corp makes up approx 0.41% of Waverton Investment Management Ltd’s portfolio.Eqis Capital Management boosted its stake in CVS in the latest quarter, The investment management firm added 757 additional shares and now holds a total of 19,495 shares of CVS Health Corp which is valued at $1,964,511. CVS Health Corp makes up approx 0.14% of Eqis Capital Management’s portfolio.
On the company’s financial health, CVS Health Corp reported $1.53 EPS for the quarter, based on the information available during the earnings call on Feb 9, 2016. Analyst had a consensus estimate of $1.53. The company had revenue of $41145.00 million for the quarter, compared to analysts expectations of $41126.27 million. The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.21 EPS.
Investors should note that on Mar 2, 2016, CVS Health Corp announced a cash dividend of $0.4250. The company’s management has announced Apr 20, 2016 as the ex-dividend date and fixed the record date on Apr 22, 2016. The payable date has been fixed on May 2, 2016.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Shares were Reiterated by Mizuho on Feb 10, 2016 to “Buy” and Lowered the Price Target to $ 104 from a previous price target of $113 .CVS Health Corp was Initiated by Atlantic Equities to “Overweight” on Feb 3, 2016.
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.